[Ertolan, a new corticoid-antihistamine therapeutic combination in ointment form].
D000152:Acne Vulgaris / Q000188:drug therapy; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003877:Dermatitis, Contact / Q000188:drug therapy; D004357:Drug Synergism; D004485:Eczema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D006229:Hand Dermatoses / Q000188:drug therapy; D006801:Humans; D007402:Intertrigo / Q000188:drug therapy; D009824:Ointments; D010632:Pheniramine / Q000627:therapeutic use*; D011239:Prednisolone; D011565:Psoriasis / Q000188:drug therapy; D012393:Rosacea / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D009824:Ointments; D010632:Pheniramine; D011239:Prednisolone
Ertolan, eine neue Kortikoid-Antihistamin-Chemotherapeutikum-Kombination in Salbenform.